DE69213409D1 - Bioysnthetische gehirnruckenmarkflussigkeitskontrolle und verfahren zu deren herstellung - Google Patents

Bioysnthetische gehirnruckenmarkflussigkeitskontrolle und verfahren zu deren herstellung

Info

Publication number
DE69213409D1
DE69213409D1 DE69213409T DE69213409T DE69213409D1 DE 69213409 D1 DE69213409 D1 DE 69213409D1 DE 69213409 T DE69213409 T DE 69213409T DE 69213409 T DE69213409 T DE 69213409T DE 69213409 D1 DE69213409 D1 DE 69213409D1
Authority
DE
Germany
Prior art keywords
production
bioysnthetic
liquid control
brain pressure
market liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69213409T
Other languages
English (en)
Other versions
DE69213409T2 (de
Inventor
Kathryn Herring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dade Behring Inc
Original Assignee
Dade International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade International Inc filed Critical Dade International Inc
Application granted granted Critical
Publication of DE69213409D1 publication Critical patent/DE69213409D1/de
Publication of DE69213409T2 publication Critical patent/DE69213409T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/80—Multi-analyte reference solutions containing cholesterol, glucose and the like
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69213409T 1991-03-07 1992-02-24 Bioysnthetische gehirnruckenmarkflussigkeitskontrolle und verfahren zu deren herstellung Expired - Fee Related DE69213409T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66587491A 1991-03-07 1991-03-07
PCT/US1992/001555 WO1992015887A1 (en) 1991-03-07 1992-02-24 Biosynthetic cerebrospinal fluid control and method of use

Publications (2)

Publication Number Publication Date
DE69213409D1 true DE69213409D1 (de) 1996-10-10
DE69213409T2 DE69213409T2 (de) 1997-04-24

Family

ID=24671910

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69213409T Expired - Fee Related DE69213409T2 (de) 1991-03-07 1992-02-24 Bioysnthetische gehirnruckenmarkflussigkeitskontrolle und verfahren zu deren herstellung

Country Status (10)

Country Link
US (2) US5308459A (de)
EP (2) EP0711786A2 (de)
JP (1) JPH05506721A (de)
AT (1) ATE142345T1 (de)
AU (4) AU648159B2 (de)
CA (1) CA2081481A1 (de)
DE (1) DE69213409T2 (de)
DK (1) DK0546127T3 (de)
ES (1) ES2093823T3 (de)
WO (1) WO1992015887A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5144950A (en) * 1990-08-30 1992-09-08 Vitatron Medical B.V. Rate controlled pacemaker system using ar interval for rate control
GB9414651D0 (en) * 1994-07-20 1994-09-07 Gene Pharming Europ Bv Separation of human serum albumin
US6660486B2 (en) * 2001-05-31 2003-12-09 Bio-Rad Laboratories, Inc. FXIII detection for verifying serum sample and sample size and for detecting dilution
WO2009102611A2 (en) * 2008-02-15 2009-08-20 Bayhill Therapeutics, Inc. Methods of predicting responsiveness of ms patients to immune-based therapy
CN105738636B (zh) * 2016-01-26 2017-08-29 宁波天康生物科技有限公司 一种液体pa质控血清保存液及其制备方法
CN114058636A (zh) * 2021-11-16 2022-02-18 大连润生康泰医学检验实验室有限公司 一种转甲状腺素蛋白基因的克隆、表达与纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753925A (en) * 1972-03-24 1973-08-21 Baxter Laboratories Inc Cerebrospinal fluid control standard
JPS5082224A (de) * 1973-11-06 1975-07-03
FR2439017A1 (fr) * 1978-10-18 1980-05-16 Kabivitrum Sa Liquide cephalo-rachidien artificiel
US4450841A (en) * 1982-03-03 1984-05-29 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4874694A (en) * 1987-04-07 1989-10-17 The Rockefeller University Use of phosphoprotein patterns for diagnosis of neurological and psychiatric disorders
US4892814A (en) * 1987-06-22 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Method for distinguishing Creutzfeldt-Jakob disease from other dementias

Also Published As

Publication number Publication date
JPH05506721A (ja) 1993-09-30
AU1239495A (en) 1995-06-01
ATE142345T1 (de) 1996-09-15
WO1992015887A1 (en) 1992-09-17
AU648159B2 (en) 1994-04-14
US5427949A (en) 1995-06-27
US5308459A (en) 1994-05-03
EP0546127B1 (de) 1996-09-04
AU1458392A (en) 1992-10-06
DE69213409T2 (de) 1997-04-24
DK0546127T3 (da) 1996-11-04
EP0711786A3 (de) 1996-05-22
AU674623B2 (en) 1997-01-02
AU5499994A (en) 1994-04-21
AU670157B2 (en) 1996-07-04
EP0711786A2 (de) 1996-05-15
CA2081481A1 (en) 1992-09-08
AU1239695A (en) 1995-06-22
EP0546127A1 (de) 1993-06-16
ES2093823T3 (es) 1997-01-01
AU1239795A (en) 1995-07-13
AU667179B2 (en) 1996-03-07

Similar Documents

Publication Publication Date Title
DK0391526T3 (da) Antistofoprensningsfremgangsmåde
FR2603581B1 (fr) Procede pour isoler et purifier des aminoacides par chromatographie
ATA133087A (de) Anlage und verfahren zum herstellen von alkoholarmem wein
FI103974B1 (fi) Menetelmä proteiinin puhdistamiseksi
ATE154033T1 (de) Verfahren zur reinigung von proteinen
DE69213409D1 (de) Bioysnthetische gehirnruckenmarkflussigkeitskontrolle und verfahren zu deren herstellung
FR2505326B1 (fr) Procede de separation et de purification d'acides amines
DE69025961D1 (de) Verfahren zur Reinigung von Interleukin-4
ATE173272T1 (de) Verfahren zur reaktivierung von gereinigten membranproteinen
DE3650268D1 (de) Glutamatcopolymer enthaltendes optisches Filter und Verfahren zur Herstellung eines Glutamatcopolymer enthaltenden optischen Filters.
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
FR2563443B1 (fr) Procede et dispositif de separation par ultrafiltration de substances en solution ou en suspension, application a la plasmapherese
AT381094B (de) Verfahren zur herstellung von neuen 2, 4, 8-triazaphenalenium-salzen sowie von deren geometrischen und optischen isomeren
DE3582681D1 (de) Verfahren zum formen des umfangrandes von kontaktlinsen.
RO93653A2 (ro) Procedeu de imbogatire in proteina a celofurajului
RO93336A2 (ro) Procedeu de durificare a pieselor care lucreaza in medii corozive apoase si acide
RO91391A2 (ro) Procedeu de purificare a 3,4-dimetil-5-sulfanilamidoizoxazolului
KR950003314A (ko) 인간 표피 성장 인자의 정제시 색소성분의 제거방법
IT8841610A0 (it) Mezzi e metodo per l'ottimizzazione dei processi produttivi.
DE3790806T1 (de) Brennstoffregelventilanordnung, deren teile und verfahren zu deren herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8327 Change in the person/name/address of the patent owner

Owner name: DADE BEHRING, INC.(N.D.GES.DES STAATES DELAWARE),